These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34623702)

  • 1. Serum Substance P Is Increased in Parkinson's Disease and Correlates with Motor Impairment.
    Schirinzi T; Maftei D; Ralli M; Greco A; Mercuri NB; Lattanzi R; Severini C
    Mov Disord; 2022 Jan; 37(1):228-230. PubMed ID: 34623702
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatments for Parkinson's Disease -Essential Knowledge for General Physicians - Topics: V. Motor Disabilities with Ageing and Parkinson's Disease.
    Murata M
    Nihon Naika Gakkai Zasshi; 2015 Aug; 104(8):1572-7. PubMed ID: 30160452
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatments for Parkinson's Disease -Essential Knowledge for General Physicians - Topics: II. Familial Parkinson's Disease Causative Genes Shed Light on the Molecular Pathogenesis].
    Sato S; Nishioka K; Hattori N
    Nihon Naika Gakkai Zasshi; 2015 Aug; 104(8):1552-7. PubMed ID: 30160417
    [No Abstract]   [Full Text] [Related]  

  • 4. Higher serum triglyceride levels are associated with Parkinson's disease mild cognitive impairment.
    Huang X; Ng SY; Chia NS; Acharyya S; Setiawan F; Lu Z; Tan YJ; Ng E; Wen MC; Ng ASL; Tay KY; Au WL; Tan EK; Tan LC
    Mov Disord; 2018 Dec; 33(12):1970-1971. PubMed ID: 30345542
    [No Abstract]   [Full Text] [Related]  

  • 5. Everyday Language Difficulties in Parkinson's Disease: Caregiver Description and Relationship With Cognition, Activities of Daily Living, and Motor Disability.
    Wolff L; Benge J
    Am J Speech Lang Pathol; 2019 Feb; 28(1):165-173. PubMed ID: 31072160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceruloplasmin in Parkinson's disease and the nonmotor symptoms.
    Zhao X; Shao Z; Zhang Y; Liu F; Liu Z; Liu Z
    Brain Behav; 2018 Jun; 8(6):e00995. PubMed ID: 29733522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological correlates of olfactory dysfunction in Parkinson's disease.
    Morley JF; Duda JE
    J Neurol Sci; 2011 Nov; 310(1-2):228-30. PubMed ID: 21658728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
    Cilia R; Cereda E; Akpalu A; Sarfo FS; Cham M; Laryea R; Obese V; Oppon K; Del Sorbo F; Bonvegna S; Zecchinelli AL; Pezzoli G
    Brain; 2020 Aug; 143(8):2490-2501. PubMed ID: 32844196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease.
    Tambasco N; Paolini Paoletti F; Chiappiniello A; Lisetti V; Nigro P; Eusebi P; Chiarini P; Romoli M; Brahimi E; Simoni S; Filidei M; Floridi P; Tarducci R; Parnetti L; Calabresi P
    Neurobiol Aging; 2019 Aug; 80():91-98. PubMed ID: 31103636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    J Neurol; 2013 Feb; 260(2):438-44. PubMed ID: 22911513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.
    Minett T; Su L; Mak E; Williams G; Firbank M; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn D; O'Brien JT
    J Neurol; 2018 Jul; 265(7):1528-1539. PubMed ID: 29696499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease.
    Grace J; Amick MM; D'Abreu A; Festa EK; Heindel WC; Ott BR
    J Int Neuropsychol Soc; 2005 Oct; 11(6):766-75. PubMed ID: 16248912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter degeneration profile in the cognitive cortico-subcortical tracts in Parkinson's disease.
    Hanganu A; Houde JC; Fonov VS; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Collins LD; Descoteaux M; Monchi O
    Mov Disord; 2018 Jul; 33(7):1139-1150. PubMed ID: 29683523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
    Bronnick K; Emre M; Tekin S; Haugen SB; Aarsland D
    Mov Disord; 2011 Apr; 26(5):824-9. PubMed ID: 21437985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor and non-motor symptoms in old-age onset Parkinson's disease patients.
    Mendonça MD; Lampreia T; Miguel R; Caetano A; Barbosa R; Bugalho P
    J Neural Transm (Vienna); 2017 Jul; 124(7):863-867. PubMed ID: 28314948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.
    Smith CR; Cullen B; Sheridan MP; Cavanagh J; Grosset KA; Grosset DG
    Acta Neurol Scand; 2020 Jun; 141(6):500-508. PubMed ID: 32002988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.